TC-220（TAE Life Sciences）

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameTC-220（TAE Life Sciences）
Drug Alias NameTC220TC-220
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Boron
Mechanisms of ActionBoron neutron capture therapy
TargetsUpdating
Therapy Area/IndicationsHead and Neck NeoplasmsBreast NeoplasmsMelanoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTAE Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTAE Life Sciences
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsBreast NeoplasmsMelanoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A